Clinical Trials Sponsored by M.D. Anderson Cancer Center - Houston

Total 5463 results

M.D. Anderson Cancer Center

Withdrawn

Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome

Breast Carcinoma
M.D. Anderson Cancer Center

Completed

Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center

Completed

Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab

Lymphoma

United States
M.D. Anderson Cancer Center

Completed

High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer

Disorders of Breast

United States
M.D. Anderson Cancer Center

Completed

Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway

Peritoneal Cancer

United States
M.D. Anderson Cancer Center

Completed

A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms

Bone Metastases

United States
M.D. Anderson Cancer Center

Completed

Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord Compression

Metastatic Epidural Spinal Cord Compression

United States
M.D. Anderson Cancer Center

Terminated

Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI

Head and Neck Cancer

United States
M.D. Anderson Cancer Center

Completed

Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)

Leukemia | Chronic Lymphocytic Leukemia

United States
M.D. Anderson Cancer Center

Completed

REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast Reconstruction

Mammoplasty Patient

United States
M.D. Anderson Cancer Center

Completed

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Melanoma

United States
M.D. Anderson Cancer Center

Completed

A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue

Leukemia | CLL

United States
M.D. Anderson Cancer Center

Terminated

Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast Cancer

Breast Neoplasm | Inflammatory Breast Carcinoma

United States
M.D. Anderson Cancer Center

Completed

Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer

Gastrointestinal Cancer

United States
M.D. Anderson Cancer Center

Completed

Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease

Liver Cancer

United States
M.D. Anderson Cancer Center

Completed

Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer

Advanced Cancers

United States
M.D. Anderson Cancer Center

Active, not recruiting

Prevalence of Endometrial Abnormalities In Obese Women

Obesity

United States
M.D. Anderson Cancer Center

Completed

Dexamethasone Dyspnea Study

Solid Tumors | Advanced Cancers | Hematologic Disorder

United States
M.D. Anderson Cancer Center

Completed

Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance

Advanced Cancer | Solid Tumors

United States
M.D. Anderson Cancer Center

Active, not recruiting

Evaluating Materials to Educate Patients About Cervical Dysplasia

Education | Cervical Dysplasia

United States
M.D. Anderson Cancer Center

Unknown

Xerostomia Pilot Fudan: Acupuncture for Prevention of Radiation-Induced Xerostomia

Head and Neck Cancer | Xerostomia

China
M.D. Anderson Cancer Center

Completed

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Lymphoma | Disorder Related to Bone Marrow Transplantation

United States
M.D. Anderson Cancer Center

Completed

Evaluation of Robot-Assisted Surgery in Gynecologic Oncology

Gynecologic Cancer

United States
M.D. Anderson Cancer Center

Completed

Wearable Exercise Trackers in Cancer Rehabilitation

Malignant Neoplasms of Independent (Primary) Multiple Sites | Benign Neoplasms | In Situ Neoplasms

United States
M.D. Anderson Cancer Center

Completed

Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

Leukemia | Acute Lymphoblastic Leukemia

United States
M.D. Anderson Cancer Center

Terminated

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma

Uterine Cancer

United States
M.D. Anderson Cancer Center

Completed

Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes

Multiple Endocrine Neoplasia

United States
M.D. Anderson Cancer Center

Completed

Effect of Physician Attire on Patients' Preference of Physician

Malignant Neoplasms of Independent (Primary) Multiple Sites

United States
M.D. Anderson Cancer Center

Completed

Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging

Cancer of Lymph Node

United States
M.D. Anderson Cancer Center

Completed

Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

Ductal Carcinoma In Situ

United States
M.D. Anderson Cancer Center

Completed

Melanoma Risk-Reduction Among Patients and Family Members

Melanoma

United States
M.D. Anderson Cancer Center

Completed

Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Primary Breast Cancer Occurring Concomitant With Pregnancy

Breast Cancer | Pregnancy

United States
M.D. Anderson Cancer Center

Completed

Study of Vemurafenib, Carboplatin, and Paclitaxel

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Simultaneous Integrated Boost (SIB) in Esophageal Cancer

Esophageal Cancer

United States
M.D. Anderson Cancer Center

Completed

Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)

Leukemia

United States
M.D. Anderson Cancer Center

Completed

SRS Study in Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma | Brain Cancer

United States
M.D. Anderson Cancer Center

Completed

A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United States
M.D. Anderson Cancer Center

Completed

Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome

Leukemia

United States
M.D. Anderson Cancer Center

Completed

REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)

Heart Failure | Cancer Treatment Induced Left Ventricular Dysfunction

United States
M.D. Anderson Cancer Center

Terminated

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

Ewing's Sarcoma

United States
M.D. Anderson Cancer Center

Unknown

Understanding Patient's Knowledge and Use of Acetaminophen

Liver Failure

United States
M.D. Anderson Cancer Center

Completed

Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma

Lymphoma | Advanced Cancers

United States
M.D. Anderson Cancer Center

Withdrawn

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

Lymphoma | Leukemia | Blood And Marrow Transplantation
M.D. Anderson Cancer Center

Unknown

Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism

Primary Hyperparathyroidism

United States
M.D. Anderson Cancer Center

Terminated

Metformin in Non Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease

Lymphoma

United States
M.D. Anderson Cancer Center

Terminated

Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)

Lymphoma

United States
M.D. Anderson Cancer Center

Completed

Melanoma Vaccine With Peptides and Leuprolide

Melanoma

United States

3

Subscribe